SNDA Sonida Senior Living (SNDA) Insider Trading, Ownership & Congress Trades
Healthcare Services · Services-nursing & personal care facilities · CIK 0001043000
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
128
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $51.2M priced
What the filings say about SNDA
Insiders, 180 days
-$11.0M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2026-04-07
Sonida Senior Living insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, SONIDA SENIOR LIVING, INC. insiders sold a net $11.0M of stock across 74 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Aug 28, 2026.
- The trade is 97.2% of the 100,373 shares held after it.
- 1 other insider sold within 30 days.
- 128 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Simanovsky Michael sold about $3.7M of SNDA on Sep 1, 2026; 1 other insider sold within 30 days and 128 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Aug 27, 2026.
- The trade is 10.8% of the 202,569 shares held after it.
- 1 other insider sold within 30 days.
- 128 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Simanovsky Michael sold about $831.6K of SNDA on Aug 28, 2026; 1 other insider sold within 30 days and 128 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Aug 27, 2026.
- The trade is 2.3% of the 197,954 shares held after it.
- 1 other insider sold within 30 days.
- 128 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Simanovsky Michael sold about $181.1K of SNDA on Aug 28, 2026; 1 other insider sold within 30 days and 128 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Aug 26, 2026.
- The trade is 6.7% of the 224,361 shares held after it.
- 1 other insider sold within 30 days.
- 128 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Simanovsky Michael sold about $585.0K of SNDA on Aug 27, 2026; 1 other insider sold within 30 days and 128 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 25, 2026.
- The trade is 6.3% of the 239,361 shares held after it.
- 1 other insider sold within 30 days.
- 128 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Simanovsky Michael sold about $617.6K of SNDA on Aug 26, 2026; 1 other insider sold within 30 days and 128 funds added in the latest 13F quarter.74 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$11.0M over 180 days
-$10.9M over 90 days · -$10.6M of it by a 10%+ holder
below 68% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
128 funds bought in last quarter
below 53% of Healthcare Services
Revenue
+25.2% year over year
more than 76% of Healthcare Services
Margin
-18.6% net margin
below 75% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
12.8% of the float short (float per yahoo 2026-10-26) · 8.8 days to cover · settled 2026-09-30
more than 76% of Healthcare Services
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch SNDA
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+28.7%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns SNDA: institutional holders (13F)
13F holdings, latest reported quarter
14,605,874 sh
$595.9M
3,291,753 sh
$134.3M
2,375,656 sh
$96.9M
2,218,503 sh
$90.5M
1,903,621 sh
$77.7M
Congress trades in SNDA
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-04-07 · disclosed 8 days later
$1,001 - $15,000
Exchanged 2026-03-31 · disclosed 15 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
SNDA planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
SNDA mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$2.6M position · as of 2026-06-30
1.8%
First Eagle US Smid Cap Opportunity Fund
$1.7M position · as of 2026-07-31
1.6%
Nuveen Small Cap Value Opportunities Fund
$3.5M position · as of 2026-06-30
1.1%
Kennedy Capital Small Cap Value Fund
$725.4K position · as of 2026-06-30
0.8%
AB Global Real Estate Investment Fund II
$1.1M position · as of 2026-07-31
0.6%
TEXAS CAPITAL TEXAS EQUITY INDEX ETF
$166.3K position · as of 2026-06-30
0.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Brandon M. Ribar
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.2M
$3.9M
$1.4M
+40%
n/a
2024
$3.2M
$4.2M
$1.7M
+159%
n/a
2023
$1.8M
$954.9K
$1.1M
-22%
n/a
2022
$1.9M
$128.6K
$1.1M
+1%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $11.0M sold by insiders over 180 days, 128 funds added last quarter. Each figure is a federal filing, dated the day it went public.
SNDA financials
Revenue growth
+25.2%
XBRL, annual
Net margin
-18.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$526.0M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM SNDA
| FY Dec 2025 | $381.1M |
| FY Dec 2024 | $304.3M |
| FY Dec 2023 | $255.3M |
| FY Dec 2022 | $238.4M |
| FY Dec 2021 | $234.7M |
| Jun 2026 | $207.6M |
| Mar 2026 | $122.6M |
| Dec 2025 | $97.7M |
| Sep 2025 | $98.0M |
| Jun 2025 | $93.5M |
| Mar 2025 | $91.9M |
| Dec 2024 | $91.9M |
| Sep 2024 | $74.8M |
At each fiscal year end
Single quarter
Net margin, TTM
-23.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM SNDA
| FY Dec 2025 | -19.0% |
| FY Dec 2024 | -1.1% |
| FY Dec 2023 | -8.3% |
| FY Dec 2022 | -22.8% |
| FY Dec 2021 | +53.5% |
| Jun 2026 | -11.8% |
| Mar 2026 | -33.6% |
| Dec 2025 | -32.2% |
| Sep 2025 | -27.4% |
| Jun 2025 | -1.7% |
| Mar 2025 | -13.6% |
| Dec 2024 | -7.3% |
| Sep 2024 | -18.4% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$52.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM SNDA
| FY Dec 2025 | -$8.9M |
| FY Dec 2024 | -$27.0M |
| FY Dec 2023 | -$7.3M |
| FY Dec 2022 | -$27.1M |
| FY Dec 2021 | -$39.2M |
| Jun 2026 | -$3.7M |
| Mar 2026 | -$42.6M |
| Dec 2025 | -$9.3M |
| Sep 2025 | $3.0M |
| Jun 2025 | $1.9M |
| Mar 2025 | -$4.5M |
| Dec 2024 | -$10.4M |
| Sep 2024 | -$5.1M |
At each fiscal year end
Single quarter
Debt to equity
1.82x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity SNDA
| FY Dec 2025 | n/a |
| FY Dec 2024 | 9.07x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 1.82x |
| Mar 2026 | 1.83x |
| Dec 2025 | n/a |
| Sep 2025 | 22.99x |
| Jun 2025 | 11.96x |
| Mar 2025 | 11.08x |
| Dec 2024 | 9.07x |
| Sep 2024 | 7.79x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.01x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt SNDA
| FY Dec 2025 | 0.04x |
| FY Dec 2024 | -0.00x |
| FY Dec 2023 | 0.02x |
| FY Dec 2022 | -0.00x |
| FY Dec 2021 | -0.04x |
| Jun 2026 | -0.01x |
| Mar 2026 | -0.01x |
| Dec 2025 | 0.04x |
| Sep 2025 | 0.03x |
| Jun 2025 | 0.02x |
| Mar 2025 | 0.01x |
| Dec 2024 | -0.00x |
| Sep 2024 | 0.00x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-27.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity SNDA
| FY Dec 2025 | -202.0% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | -27.0% |
| Mar 2026 | -21.4% |
| Dec 2025 | -202.0% |
| Sep 2025 | -88.9% |
| Jun 2025 | -306.2% |
| Mar 2025 | -493.2% |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-7.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets SNDA
| FY Dec 2025 | -8.6% |
| FY Dec 2024 | -0.4% |
| FY Dec 2023 | -3.3% |
| FY Dec 2022 | -7.8% |
| FY Dec 2021 | +17.6% |
| Jun 2026 | -7.3% |
| Mar 2026 | -5.9% |
| Dec 2025 | -8.6% |
| Sep 2025 | -5.8% |
| Jun 2025 | -4.6% |
| Mar 2025 | -5.9% |
| Dec 2024 | -0.4% |
| Sep 2024 | -1.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital SNDA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | -3.1% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed SNDA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | -2.7% |
| FY Dec 2022 | -2.5% |
| FY Dec 2021 | -3.1% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing SNDA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.75x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.1B
market value at close 2026-10-23 on 2026-08-07 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value SNDA
| FY Dec 2025 | $1.3B |
| FY Dec 2024 | $1.1B |
| FY Dec 2023 | $704.3M |
| FY Dec 2022 | $737.5M |
| FY Dec 2021 | $788.0M |
| Jun 2026 | $3.5B |
| Mar 2026 | $3.1B |
| Dec 2025 | $1.3B |
| Sep 2025 | $1.2B |
| Jun 2025 | $1.1B |
| Mar 2025 | $1.1B |
| Dec 2024 | $1.1B |
| Sep 2024 | $960.0M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-3.2%
TTM free cash flow over market value at close 2026-10-23
FCF yield SNDA
| FY Dec 2025 | -1.5% |
| FY Dec 2024 | -6.1% |
| FY Dec 2023 | -9.2% |
| FY Dec 2022 | -32.6% |
| FY Dec 2021 | -21.4% |
| Jun 2026 | -2.7% |
| Mar 2026 | -3.1% |
| Dec 2025 | -1.5% |
| Sep 2025 | -1.9% |
| Jun 2025 | -3.8% |
| Mar 2025 | -4.9% |
| Dec 2024 | -6.1% |
| Sep 2024 | -5.3% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing SNDA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $381.1M | $304.3M | $255.3M | $238.4M |
| Operating income | n/a | $68.7M | $57.9M | n/a |
| Net income | -$72.5M | -$3.3M | -$21.1M | -$54.4M |
| EPS (diluted) | -4.22 | -0.54 | -3.85 | -9.27 |
| Operating cash flow | $24.4M | -$1.8M | $10.7M | -$2.6M |
| Cash | $11.0M | $17.0M | $4.1M | $16.9M |
| Long-term debt | $682.5M | $635.9M | $587.1M | $625.0M |
SEC XBRL, fiscal years, as known on 2026-10-27
SNDA Stock Sonar score 6/7 axes
Find similar shapesCompareSNDA ranks highest on growth (76th percentile) and profitability (36th), and lowest on insider conviction (13th), among Healthcare Services peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SNDA filings, in plain words
Are Sonida Senior Living insiders buying or selling SNDA?
In the 180 days to 2026-10-27, Sonida Senior Living insiders were net sellers, a net $11.0M across purchases and sales reported on Form 4, by 2 sellers.
Have members of Congress traded SNDA?
Yes. In the year to 2026-10-27, 0 House members disclosed buying SNDA and 1 House member disclosed selling it; the latest on record is a sale by Rick Larsen dated 2026-04-07.
Read the full summary
In the 180 days to 2026-10-27, Sonida Senior Living insiders were net sellers of SNDA, a net $11.0M across purchases and sales reported on Form 4 by 2 sellers. Most of that figure, $10.6M, came from a holder of 10% or more rather than an officer or director. None of the 9 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 0 members of Congress disclosed buying SNDA and 1 member disclosed selling it; the latest on record is a sale by Rick Larsen dated 2026-04-07. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
